Johnson & Johnson - 54 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of May 30, 2024 is 145.28.
  • The all-time high Johnson & Johnson stock closing price was 174.35 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 175.97, which is 21.1% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 143.13, which is 1.5% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 157.76.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 153.6933 157.4723 161.4168 143.2755 145.2800 -5.84%
2023 155.3531 170.2890 172.2576 142.1979 154.2928 -8.60%
2022 162.7142 159.7478 174.3471 148.2246 168.8173 5.97%
2021 152.1307 142.1459 165.0457 139.8980 159.3101 11.45%
2020 130.6048 129.0404 142.9452 98.8897 142.9452 10.85%
2019 118.1259 110.6635 129.4559 108.9050 128.9520 15.35%
2018 113.6530 117.4284 128.0664 102.0949 111.7896 -5.14%
2017 108.0656 95.2425 120.5153 91.8880 117.8417 24.40%
2016 92.1501 80.3477 101.7141 76.5654 94.7246 15.32%
2015 78.5699 81.1598 84.1620 72.0241 82.1389 1.16%
2014 77.2477 68.7791 84.2658 65.4471 81.1986 17.34%
2013 63.8724 51.9501 72.2547 51.8768 69.2022 34.61%
2012 48.2013 46.5979 52.7198 44.5105 51.4075 10.83%
2011 44.1235 42.8725 47.1797 39.7072 46.3858 9.89%
2010 41.6425 42.6356 43.8598 38.2214 42.2105 -0.58%
2009 37.4887 38.6782 42.8202 29.9682 42.4577 11.28%
2008 40.7867 40.8791 45.6964 35.2854 38.1552 -7.77%
2007 39.1635 40.1575 42.4234 36.4990 41.3690 3.61%
2006 37.1808 36.4128 41.5538 33.5591 39.9277 12.44%
2005 37.8303 36.4412 40.3791 35.4734 35.5088 -3.36%
2004 32.0815 29.3549 36.9395 28.2512 36.7425 25.17%
2003 29.6200 30.8935 32.8893 27.5631 29.3549 -2.11%
2002 31.9568 32.3335 36.1869 23.2016 29.9890 -7.88%
2001 28.4304 27.7212 33.5839 22.7022 32.5538 13.97%
2000 24.1465 24.7616 28.5637 18.4651 28.5637 14.04%
1999 25.1223 21.9554 28.4977 20.4446 25.0463 12.46%
1998 19.8009 17.0516 23.6308 16.7738 22.2714 28.99%
1997 15.5295 12.8558 17.5443 12.8558 17.2665 34.31%
1996 12.4486 10.7255 13.8894 10.7255 12.8558 18.11%
1995 8.6918 6.8083 11.6485 6.7146 10.8846 59.14%
1994 5.7108 5.5170 6.9494 4.5086 6.8395 24.99%
1993 5.0580 5.8896 5.8896 4.3179 5.4719 -8.93%
1992 5.8195 6.5586 6.7999 5.0838 6.0085 -10.19%
1991 5.1964 4.0204 6.7485 3.7689 6.6901 62.34%
1990 3.5745 3.3680 4.1723 2.9248 4.1210 23.39%
1989 2.7865 2.3003 3.3399 2.3003 3.3399 42.63%
1988 2.2001 2.0966 2.4092 1.8884 2.3416 16.51%
1987 2.2966 1.7821 2.7928 1.7218 2.0097 15.79%
1986 1.6686 1.3429 1.9440 1.2360 1.7356 27.43%
1985 1.1378 0.8964 1.4172 0.8838 1.3620 49.85%
1984 0.8472 0.9937 1.0302 0.6983 0.9089 -8.53%
1983 1.0965 1.1754 1.2147 0.9541 0.9937 -15.66%
1982 0.9591 0.8488 1.2110 0.7578 1.1782 36.94%
1981 0.7816 0.7522 0.8804 0.6564 0.8604 14.54%
1980 0.5898 0.5622 0.7531 0.4904 0.7512 29.41%
1979 0.5208 0.5289 0.5860 0.4709 0.5805 10.49%
1978 0.5411 0.5226 0.6287 0.4619 0.5254 -1.76%
1977 0.4855 0.5334 0.5348 0.4299 0.5348 0.41%
1976 0.5859 0.6079 0.6492 0.4916 0.5326 -12.03%
1975 0.5974 0.5547 0.6648 0.4928 0.6054 12.01%
1974 0.6557 0.7410 0.7906 0.5008 0.5405 -27.70%
1973 0.7865 0.8482 0.8615 0.6929 0.7476 -13.22%
1972 0.7772 0.6428 0.8715 0.6239 0.8615 32.99%
1971 0.5585 0.3745 0.6503 0.3745 0.6478 73.72%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $347.621B $85.159B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $771.283B 111.47
Novo Nordisk (NVO) Denmark $595.406B 45.75
Merck (MRK) United States $318.880B 58.02
AbbVie (ABBV) United States $273.339B 14.12
AstraZeneca (AZN) United Kingdom $235.884B 20.51
Novartis AG (NVS) Switzerland $203.092B 14.40
Pfizer (PFE) United States $157.645B 19.59
Sanofi (SNY) $120.342B 11.35
Innoviva (INVA) United States $0.958B 6.73